GEFTINAT GEFTINIB TABLETS

Get a Price/Quote

GEFTINAT GEFTINIB TABLETS Specification

Salt Composition
Gefitinib 250mg

Indication
Non-Small Cell Lung Cancer (NSCLC)

Dosage Form
Tablet

Feature
Oral targeted therapy, EGFR tyrosine kinase inhibitor

Ingredients
Gefitinib and excipients

Application
Oncology/Anticancer Therapy

Physical Color/Texture
Light brownish, biconvex, round tablets

Fermentation Smell
Odorless

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Shelf Life
24 months

GEFTINAT GEFTINIB TABLETS Trade Information

Packaging Details
PACK OF 30 TABLETS

Main Domestic Market
All India

About GEFTINAT GEFTINIB TABLETS

Geftinat- Gefitinib

Geftinat contains gefitinib and belongs to a class of anti-cancer medications called epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.Geftinat is used for the treatment of non-small cell lung cancer.

Specification :-

Brand name: Geftinat
Contains: Gefitinib
Strength: Geftinat 250 Mg
Packing : 1 Bottle Of Geftinat Contains 30 Tablets
Manufactured By : Natco

Note :-Geftinat Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug............

Targeted Therapy for NSCLC

GEFTINAT Gefitinib Tablets are tailored for patients diagnosed with non-small cell lung cancer. By targeting the epidermal growth factor receptor (EGFR), the medicine disrupts signals necessary for tumor growth. This precision approach helps optimize treatment outcomes for eligible patients while minimizing the impact on healthy tissues.

Convenient Oral Administration

With a straightforward oral route, GEFTINAT tablets offer a less invasive alternative to intravenous therapies. The easy-to-administer, once-daily dosage simplifies adherence and can be taken at home, reducing the need for frequent hospital visits. Always follow your oncologists instructions for best results.

Strict Prescription and Safety Guidelines

GEFTINAT Gefitinib is available only on prescription from an oncologist, emphasizing its potent nature and the need for professional supervision. Consult your oncologist for suitability and disclose any ingredient allergies, as hypersensitivity is a contraindication. Keep the tablets out of reach of children and store as directed for guaranteed efficacy.

FAQs of GEFTINAT GEFTINIB TABLETS:

Q: How should GEFTINAT Gefitinib Tablets be taken for optimal benefit?

A: GEFTINAT tablets should be taken orally, usually once daily as prescribed by your oncologist. The medication can be taken with or without food, but its essential to follow your doctors instructions for timing and duration to achieve the best therapeutic outcome.

Q: What is the primary indication for using GEFTINAT Gefitinib Tablets?

A: GEFTINAT Gefitinib Tablets are primarily indicated for the treatment of non-small cell lung cancer (NSCLC), acting as a targeted therapy for patients with specific EGFR mutations as determined by an oncologist.

Q: When should GEFTINAT not be used?

A: Patients should avoid taking GEFTINAT Gefitinib if they have a known hypersensitivity to Gefitinib or any of the tablets inactive ingredients. Always discuss any allergies or previous adverse reactions with your healthcare provider before starting treatment.

Q: Where should GEFTINAT Tablets be stored to maintain their shelf life?

A: Store GEFTINAT Tablets in a cool, dry place below 30C. Keep them protected from light and moisture, and ensure the tablets remain in their blister pack until use for maximum potency throughout the 24-month shelf life.

Q: What common side effects can occur with GEFTINAT therapy?

A: Common side effects may include diarrhoea, skin rash, dry skin, and loss of appetite. If you experience severe or persistent symptoms, notify your oncologist promptly for further guidance.

Q: What benefits does GEFTINAT offer compared to traditional chemotherapy?

A: GEFTINAT provides targeted therapy by selectively inhibiting the EGFR pathway, potentially reducing damage to healthy cells and leading to fewer systemic side effects than conventional chemotherapy methods.

Q: Who can prescribe GEFTINAT Gefitinib Tablets?

A: Only a qualified oncologist can prescribe GEFTINAT Gefitinib Tablets. The medication is regulated and sold exclusively on prescription to ensure patient safety and appropriate use within oncology care.

Tell us about your requirement